Published online January 2008 | e-ISSN: 1460-2091 | DOI: https://dx.doi.org/10.1093/jac/dkn010Keywords: drug utilization; penicillins plus β-lactamase inhibitors; fluoroquinolones; glycopeptides; third-generation cephalosporins
